Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rakel Fuglsang Johansen"'
Autor:
Anna Dons-Jensen, Anne-Mette Hvas, Esben Thyssen Vestergaard, Rakel Fuglsang Johansen, Sascha Siig Horup
Publikováno v:
Dons-Jensen, A, Horup, S S, Hvas, A-M, Vestergaard, E T & Johansen, R F 2022, ' Ghrelin, growth hormone and insulin-like growth Factor-I levels in people with protein C deficiency ', Scandinavian Journal of Clinical and Laboratory Investigation, vol. 82, no. 6, pp. 435-438 . https://doi.org/10.1080/00365513.2022.2114104
The primary objective of this study was to examine if people with protein C deficiency, which is a natural anticoagulant and also an endogenous acyl ghrelin peptidase, have elevated circulating levels of acyl ghrelin. The clinical trial was conducted
Background Assessment of residents’ clinical skills using Case-based Discussion traditionally involves a one-to-one discussion with a supervisor. This entails a subjective, and maybe unequal, assessment of the resident, which can only be overcome w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba94e32be2cb9d8e4c6cbf92b2892107
https://doi.org/10.21203/rs.3.rs-41171/v1
https://doi.org/10.21203/rs.3.rs-41171/v1
Autor:
Rakel Fuglsang Johansen, Helle Linnebjerg, Esben Søndergaard, Eric Chen Quin Lam, Søren Nielsen, Scott J. Jacober, Parag Garhyan, Niels Porksen
Publikováno v:
Johansen, R F, Søndergaard, E, Linnebjerg, H, Garhyan, P, Lam, E C Q, Porksen, N, Jacober, S J & Nielsen, S 2018, ' Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes ', Diabetes, Obesity and Metabolism, vol. 20, no. 2, pp. 419-426 . https://doi.org/10.1111/dom.13087
Aims In patients with type 1 diabetes, basal insulin peglispro (BIL) lowers weight and increases plasma triglycerides (TG) and hepatic fat relative to insulin glargine (GL). To explain this, we hypothesised that BIL's attenuated peripheral effects ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d7d55340c6c6ac4e119fdd899456bd
https://pure.au.dk/portal/da/publications/attenuated-suppression-of-lipolysis-explains-increases-in-triglyceride-secretion-and-concentration-with-basal-insulin-peglispro-bil-relative-to-insulin-glargine-treatment-in-patients-with-type-1-diabetes(474ec6d2-b008-4166-9756-8c1c4d626969).html
https://pure.au.dk/portal/da/publications/attenuated-suppression-of-lipolysis-explains-increases-in-triglyceride-secretion-and-concentration-with-basal-insulin-peglispro-bil-relative-to-insulin-glargine-treatment-in-patients-with-type-1-diabetes(474ec6d2-b008-4166-9756-8c1c4d626969).html
Publikováno v:
Søndergaard, E, Johansen, R F, Jensen, M D & Nielsen, S 2017, ' Postprandial VLDL-TG metabolism in type 2 diabetes ', Metabolism, vol. 75, pp. 25-35 . https://doi.org/10.1016/j.metabol.2017.07.002
Background Type 2 diabetes is associated with excess postprandial lipemia due to accumulation of chylomicrons and VLDL particles. This is a risk factor for development of cardiovascular disease. However, whether the excess lipemia is associated with